Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Chamuleau Me"'
Autor:
Chamuleau Me, van Luijn Mm, Gert J. Ossenkoppele, van de Loosdrecht Aa, van den Ancker W, van Ham Sm
Publikováno v:
Immunotherapy, 2(1), 85-97. Future Medicine Ltd.
van Luijn, M M, van den Ancker, W, Chamuleau, M E D, Ossenkoppele, G J, van Ham, S M & van de Loosdrecht, A A 2010, ' Impaired antigen presentation in neoplasia: basic mechanisms and implications for acute myeloid leukemia ', Immunotherapy, vol. 2, no. 1, pp. 85-97 . https://doi.org/10.2217/imt.09.84
van Luijn, M M, van den Ancker, W, Chamuleau, M E D, Ossenkoppele, G J, van Ham, S M & van de Loosdrecht, A A 2010, ' Impaired antigen presentation in neoplasia: basic mechanisms and implications for acute myeloid leukemia ', Immunotherapy, vol. 2, no. 1, pp. 85-97 . https://doi.org/10.2217/imt.09.84
During onset, treatment and progression of acute myeloid leukemia (AML), inadequate immune responses against certain myeloid leukemic blasts might be associated with the occurrence of minimal residual disease and subsequent relapse. Several studies o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92adcf3c87ab7a37ba6a6cd66ad89bb
https://research.vumc.nl/en/publications/964ba437-0e01-4d5d-bd4b-45eb3fa060e8
https://research.vumc.nl/en/publications/964ba437-0e01-4d5d-bd4b-45eb3fa060e8
Autor:
Zinzani PL; University of Bologna, Italy pierluigi.zinzani@unibo.it., Karlin L; Centre Hospitalier Lyon-Sud, Pierre-Bénite, France., Radford J; University of Manchester and The Christie NHS Foundation Trust, UK., Caballero D; Hospital Universitario de Salamanca, Spain., Fields P; Guy's Hospital, London, UK., Chamuleau ME; Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands., d'Amore F; Aarhus University Hospital, Denmark., Haioun C; Hôpital Henri Mondor, Créteil, France., Thieblemont C; Hôpital Saint Louis, Paris, France., González-Barca E; Institut Català d'Oncologia, Barcelona, Spain., García CG; Hospital Universitario 12 de Octubre, Madrid, Spain., Johnson PW; NIHR/CRUK Experimental Cancer Medicine Centre, University of Southampton, UK., van Imhoff GW; University Medical Center Groningen, University of Groningen, The Netherlands., Ng T; Kyowa Kirin Pharmaceutical Development, Inc., Galashiels, Scotland., Dwyer K; Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA., Morschhauser F; Unité GRITA, Université de Lille 2, France.
Publikováno v:
Haematologica [Haematologica] 2016 Oct; Vol. 101 (10), pp. e407-e410. Date of Electronic Publication: 2016 Jul 14.
Autor:
van Gelder M; Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands., van Oers MH; Department of Hematology and Lymphoma and Myeloma Center, Academic Medical Center, Amsterdam, The Netherlands., Alemayehu WG; HOVON Data Center, Erasmus Medical Center, Rotterdam, The Netherlands., Abrahamse-Testroote MC; Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands., Cornelissen JJ; Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands., Chamuleau ME; Department of Hematology, Free University Medical Center, Amsterdam, The Netherlands., Zachée P; Department of Hematology, Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerpen, Belgium., Hoogendoorn M; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Petersen EJ; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Beeker A; Department of Internal Medicine, Spaarne Ziekenhuis, Hoofddorp, The Netherlands., Timmers GJ; Department of Internal Medicine, Ziekenhuis Amstelland, Amstelveen, The Netherlands., Verdonck L; Department of Internal Medicine, Isala Klinieken, Zwolle, The Netherlands., Westerman M; Department of Internal Medicine, Medisch Centrum Alkmaar, Alkmaar, The Netherlands., de Weerdt O; Department of Internal Medicine, Antonius ziekenhuis Nieuwegein, Nieuwegein, The Netherlands., Kater AP; Department of Hematology and Lymphoma and Myeloma Center, Academic Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2016 Jun; Vol. 51 (6), pp. 799-806. Date of Electronic Publication: 2016 Feb 15.
Autor:
de Jonge AV; VU University Medical Centre, Department of Haematology, Amsterdam, The Netherlands., Roosma TJ; VU University Medical Centre, Department of Haematology, Amsterdam, The Netherlands., Houtenbos I; Spaarne Gasthuis, Department of Internal Medicine, Haarlem, The Netherlands., Vasmel WL; Sint Lucas Andreas Hospital, Department of Haematology, Amsterdam, The Netherlands., van de Hem K; Zaans Medical Centre, Department of Internal Medicine, Zaandam, The Netherlands., de Boer JP; Netherlands Cancer Institute, Department of Medical Oncology, Amsterdam, The Netherlands., van Maanen T; West Fries Gasthuis, Department of Internal Medicine, Hoorn, The Netherlands., Lindauer-van der Werf G; Rode Kruis Hospital, Department of Internal Medicine, Beverwijk, The Netherlands., Beeker A; Spaarne Gasthuis, Department of Internal Medicine, Hoofddorp, The Netherlands., Timmers GJ; Amstelland Hospital, Department of Internal Medicine, Amstelveen, The Netherlands., Schaar CG; Gelre Hospital, Department of Internal Medicine, Apeldoorn, The Netherlands., Soesan M; Slotervaart Hospital, Department of Internal Medicine, Amsterdam, The Netherlands., Poddighe PJ; VU University Medical Centre, Department of Clinical Genetics, Amsterdam, The Netherlands., de Jong D; VU University Medical Centre, Department of Pathology, Amsterdam, The Netherlands., Chamuleau ME; VU University Medical Centre, Department of Haematology, Amsterdam, The Netherlands. Electronic address: m.chamuleau@vumc.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2016 Mar; Vol. 55, pp. 140-6. Date of Electronic Publication: 2016 Jan 25.
Autor:
Kahn JD; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands., Chamuleau ME; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands., Westers TM; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands., Van de Ven PM; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands., van Dreunen L; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands., van Spronsen M; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands., Ossenkoppele GJ; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands., van de Loosdrecht AA; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands a.vandeloosdrecht@vumc.nl.
Publikováno v:
Haematologica [Haematologica] 2015 Jun; Vol. 100 (6), pp. e220-2. Date of Electronic Publication: 2015 Mar 06.
Autor:
Issa DE; Department of Haematology, VU University Medical Centre, Amsterdam d.issa@vumc.nl., van de Schans SA; Comprehensive Cancer Centre the Netherlands, Utrecht., Chamuleau ME; Department of Haematology, VU University Medical Centre, Amsterdam., Karim-Kos HE; Department of Public Health, Erasmus University Medical Centre Rotterdam, The Netherlands., Wondergem M; Department of Haematology, VU University Medical Centre, Amsterdam., Huijgens PC; Department of Haematology, VU University Medical Centre, Amsterdam Comprehensive Cancer Centre the Netherlands, Utrecht., Coebergh JW; Department of Public Health, Erasmus University Medical Centre Rotterdam, The Netherlands., Zweegman S; Department of Haematology, VU University Medical Centre, Amsterdam., Visser O; Comprehensive Cancer Centre the Netherlands, Utrecht.
Publikováno v:
Haematologica [Haematologica] 2015 Apr; Vol. 100 (4), pp. 525-33. Date of Electronic Publication: 2014 Dec 15.
Autor:
Wondergem MJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands m.wondergem@vumc.nl., Rizvi SN; Department of Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., Jauw Y; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Hoekstra OS; Department of Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., Hoetjes N; Department of Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., van de Ven PM; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands., Boellaard R; Department of Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., Chamuleau ME; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Cillessen SA; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands; and., Regelink JC; Department of Hematology, Meander Medisch Centrum, Amersfoort, The Netherlands., Zweegman S; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Zijlstra JM; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2015 Feb; Vol. 56 (2), pp. 216-21. Date of Electronic Publication: 2015 Jan 15.
Autor:
Jansen Of Lorkeers SJ; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., Hart E, Tang XL, Chamuleau ME, Doevendans PA, Bolli R, Chamuleau SA
Publikováno v:
Journal of cardiovascular translational research [J Cardiovasc Transl Res] 2014 Jul; Vol. 7 (5), pp. 475-82. Date of Electronic Publication: 2014 May 16.
Autor:
Wiggers TG; Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Westra G, Westers TM, Abbes AP, Strunk A, Kuiper-Kramer E, Poddighe P, van de Loosdrecht AA, Chamuleau ME
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2014 Jul; Vol. 86 (4), pp. 280-7. Date of Electronic Publication: 2013 Oct 08.
Autor:
van den Ancker W; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., van Luijn MM; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., Chamuleau ME; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., Kelder A; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., Feller N; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., Terwijn M; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., Zevenbergen A; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., Schuurhuis GJ; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., van Ham SM; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Westers TM; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands., van de Loosdrecht AA; Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: a.vandeloosdrecht@vumc.nl.
Publikováno v:
Leukemia research [Leuk Res] 2014 Jun; Vol. 38 (6), pp. 691-3. Date of Electronic Publication: 2014 Mar 25.